3-rx.comCustomer Support
3-rx.com
   
HomeAbout UsFAQContactHelp
News Center
Health Centers
Medical Encyclopedia
Drugs & Medications
Diseases & Conditions
Medical Symptoms
Med. Tests & Exams
Surgery & Procedures
Injuries & Wounds
Diet & Nutrition
Special Topics




Join our Mailing List



Syndicate

You are here : 3-RX.com > Home

Welcome to 3-RX.com, a medical and health consumer information resource containing comprehensive and unbiased information in patient-friendly language from trusted sources on over 2,500 health topics, 85 focussed health centers, and more than 18,000 drugs and medications.

Rare diseases: no reason for lower demands for studies

Oct 23, 14
Rare diseases: no reason for lower demands for studies

On behalf of the Federal Ministry of Health (BMG), the German Institute for Quality and Efficiency in Health Care (IQWiG) examined whether specific methodological aspects have to be considered in the conduct, analysis and assessment of the certainty of results of studies on rare diseases. Within the framework of the same commission, the Institute also analysed the underlying studies for the approval of so-called orphan drugs, i.e. drugs for rare diseases, in Europe.

The result: For a different approach than in more common diseases, there are neither scientific reasons nor specific designs and methods that would not also be relevant for more common diseases. This is the case for both drug and non-drug treatments. If compromises have to be made with regard to the reliability of the conclusions because of a particularly small number of participants, raising the significance level is preferable to a limitation of the external or even internal validity of the studies.
Focus on rare diseases

In the European Union diseases are classified as rare if they occur in not more than 5 per 10 000 inhabitants. Very rare diseases are diseases that affect fewer than 2 per 100 000 inhabitants. Of approximately 30 000 known diseases, 7000 to 8000 are considered rare, so that in Germany alone up to 4 million people are affected.

- Full Story - »»»    



  Findings point to an ‘off switch’ for drug resistance in cancer
  Siblings of children with autism can show signs at 18 months
  University of Calgary research leads to brain cancer clinical trial
  Exploring the connection between empathy, neurohormones and aggression
  U.S. nutrition program for mothers, infants sees falling demand
  A better way to track emerging cell therapies using MRIs
  New superfoods could help key protein keep bodies healthy
  Mobile app on emergency cardiac care aids best decisions in seconds
  “Junk” Blood Tests May Offer Life-Saving Information
  Aspirin cuts risk of clots, DVT by a third - new study
  UNC Lineberger researchers develop new approach to identify ‘drivers’ of cancer
  Train your heart to protect your mind

 
Medical Encyclopedia
Health Centers
Drugs & Medications
 

\"$alt_text\"');"); } else { echo"\"$alt_text\""; } ?>
Take a interactive Quiz:
I have a decreased need for sleep.
yes
no









Home | About Us | FAQ | Contact | Advertising Policy | Privacy Policy | Bookmark Site